Predicting the growth performance of growing-finishing pigs based on net energy and digestible lysine intake using multiple regression and artificial neural networks models
Abstract
Evaluating the growth performance of pigs in real-time is laborious and expensive, thus mathematical models based on easily accessible variables are developed. Multiple regression (MR) is the most widely used tool to build prediction models in swine nutrition, while the artificial neural networks (ANN) model is reported to be more accurate than MR model in prediction performance. Therefore, the potential of ANN models in predicting the growth performance of pigs was evaluated and compared with MR models in this study. Body weight (BW), net energy (NE) intake, standardized ileal digestible lysine (SID Lys) intake, and their quadratic terms were selected as input variables to predict ADG and F/G among 10 candidate variables. In the training phase, MR models showed high accuracy in both ADG and F/G prediction (R2ADG = 0.929, R2F/G = 0.886) while ANN models with 4, 6 neurons and radial basis activation function yielded the best performance in ADG and F/G prediction (R2ADG = 0.964, R2F/G = 0.932). In the testing phase, these ANN models showed better accuracy in ADG prediction (CCC: 0.976 vs. 0.861, R2: 0.951 vs. 0.584), and F/G prediction (CCC: 0.952 vs. 0.900, R2: 0.905 vs. 0.821) compared with the MR models. Meanwhile, the “over-fitting” occurred in MR models but not in ANN models. On validation data from the animal trial, ANN models exhibited superiority over MR models in both ADG and F/G prediction (P < 0.01). Moreover, the growth stages have a significant effect on the…
Read the paper
Related studies
- Chaos and quantum thermalization
- The Dalton quantum chemistry program system
- Cord Blood Leptin and Adiponectin as Predictors of Adiposity in Children at 3 Years of Age: A Prospective Cohort Study
- Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes
- Stable adiabatic quantum batteries
- A novel self-lipid antigen targets human T cells against CD1c(+) leukemias
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.